Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/treating-cancer-molecular-footprint-not-organ-2026a100061v?src=rss
Author :
Publish date : 2026-02-26 09:36:00
Copyright for syndicated content belongs to the linked Source.